-
Abstract Number: PB0238
Tapering of trombopoietin receptor agonist in pediatric patients with chronic ITP. Is it posible?
-
Abstract Number: PB0488
Targeted Factor V replacement during major trauma haemorrhage
-
Abstract Number: OC 56.4
Targeted panel sequencing for identifying new rare genetic variants associated with venous thromboembolism (VTE): application to 128 patients with unprovoked VTE and negative thrombophilia screening
-
Abstract Number: PB0345
Targeting platelet Glycoprotein VI with Glenzocimab: a novel mechanism of inhibition
-
Abstract Number: PB0088
Telehealth and Health Outreach Mode of HealthCare Delivery in patients with Bleeding Disorders: Experience from a Tertiary Care Centre during COVID-19 pandemic
-
Abstract Number: OC 13.3
Temporal changes in coagulation, endothelial dysfunction and fibrinolysis biomarkers are associated with illness severity in patients with COVID-19: Canadian COVID-19 Prospective Cohort Study (CanCOV)
-
Abstract Number: PB0367
Temporal labelling of ageing platelets in mice indicates differential regulation and retention of granule protein encoding mRNAs
-
Abstract Number: PB1078
TFTEM – a New Reagent to Detect Direct Oral Factor Xa Inhibitors on ROTEM Devices
-
Abstract Number: PB1334
The (T) thrombosis (I) in patients with (L) lower (L) limb (I) injuries (R) requiring (I) immobilisation (TILLIRI) study: A prospective observational multicentre study – Early Results
-
Abstract Number: PB0432
The ADAMTS-13 / von Willebrand factor (VWF) ratio as a prognostic biomarker for the development of portal vein thrombosis (PVT) in patients with compensated cirrhosis.
-
Abstract Number: OC 58.1
The amyloid peptide β increases endothelial permeability in a NADPH oxidase 1-dependent manner: a link between Alzheimer’s Disease and neurovascular inflammation
-
Abstract Number: PB0382
The antibody JAQ1 binds to both human and mouse GPVI but differently affect their function and in vivo depletion.
-
Abstract Number: PB0553
The antithrombotic protein C activator thrombin mutant W215A/E217A (AB002, E-WE) is slowly inhibited by the endogenous thrombin inhibitors antithrombin, protein C inhibitor, and heparin cofactor II
-
Abstract Number: PB0603
The assessment of ROTEM test in patients with critical form of COVID-19
-
Abstract Number: PB1216
The association between vitamin D and disease activity in adult patients with chronic primary immune thrombocytopenia
-
Abstract Number: PB1159
The Atlanta Study: Emicizumab and simoctocog alfa in previously untreated/minimally treated patients and in patients with inhibitors
-
Abstract Number: PB0389
The C-Type Lectin CD93 Regulates Platelet Activation Induced by PAR4 Stimulation
-
Abstract Number: PB0628
The characterization of clot-fibrinolysis waveform analysis and the investigation of usefulness in critical care patients with enhanced or suppressed fibrinolysis
-
Abstract Number: OC 36.1
The CLEC4M locus participates to the regulation of FV plasma levels: insights from a new genome-wide association study conducted in 4,373 participants
-
Abstract Number: VPB0995
The clinical use of idarucizumab for dabigatran reversal in Aragón (Spain), new data
-
Abstract Number: PB0425
The CLUES Study: A Critical Look at Understanding the Emotional Suffering of Blood Clot Survivors
-
Abstract Number: PB0522
The Combination of Lipocalin-2 and Calprotectin Improves Risk Assessment in Advanced and Early Peripheral Arterial Disease
-
Abstract Number: PB1290
The contribution of peptidylarginine deiminase 4 and NETs to a dysregulated VWF/ADAMTS13 axis in Staphylococcus aureus bacteremia in patients
-
Abstract Number: VPB0137
The difference of coagulation indicators between COVID-19 and Dengue Haemorrhagic Fever in Children: A Single-Centre Study
-
Abstract Number: PB0415
The effect of a gut microbiome intervention on antiphospholipid syndrome: the ROMAS study
-
Abstract Number: VPB0171
The effect of anti-coagulant agents against in vitro hemophilia A plasma coagulation and fibrinolysis potential in the presence of emicizumab
-
Abstract Number: PB1095
The Effect of Aqueous Chromolaena odorata (Acheampong leaf) extract use on Coagulation test parameters in Vitro
-
Abstract Number: PB0892
The effect of PCSK9 on platelet aggregation and on the inflammatory activation of endothelial cells
-
Abstract Number: PB0183
The Effect of Regulatory T Cell Functions and Cytokines on the Development of Inhibitor
-
Abstract Number: OC 06.1
The effect of rituximab on antiphospholipid antibody titers in patients with Antiphospholipid Syndrome.
-
Abstract Number: PB0975
The effect of rivaroxaban on the diagnostic value of D-dimer
-
Abstract Number: PB1104
The effect of sample transportation on microparticle production measured in vitro using a procoagulant phospholipid activity assay.
-
Abstract Number: PB0020
The Effects of Hyperglycemia on Endothelial Activation and the Initiation of Atherosclerosis
-
Abstract Number: PB0356
The emerging role of Kupffer cells in thrombopoietin generation
-
Abstract Number: OC 19.3
The endothelial inflammatory repertoire: a multi-omics delineation of cytokine-induced endothelial inflammation states
-
Abstract Number: PB1180
The ex vivo effects of varying factor VIII concentration on clot formation and structure in Haemophilia A patients
-
Abstract Number: OC 66.1
The Factor XII-uPAR Axis Drives Ovarian Cancer Maintenance and Progression
-
Abstract Number: VPB1047
The FV-A2086D mutation results in impaired anticoagulant function.
-
Abstract Number: PB0335
The GFI1B c.503G>T; p.(Cys168Phe) variant – a diagnostic conundrum.
-
Abstract Number: OC 41.2
The GPIbα intracellular tail is important for VWF-mediated platelet signaling events that promote platelet/neutrophil interactions under flow
-
Abstract Number: PB0890
The heparan sulfate proteoglycan perlecan induces conflicting patterns of thrombus formation upon activation of GPVI: a novel role in thrombus stability?
-
Abstract Number: PB1052
The higher activity of baboon versus human tissue factor implicates an extended exosite region
-
Abstract Number: OC 39.5
The immediate effect of COVID-19 vaccination on anticoagulation control in adolescents and young adults using vitamin K antagonists.
-
Abstract Number: PB0602
THE IMPACT OF COVID-19 PANDEMIC ON THE HEALTH AND LIFESTYLE HEMOPHILIA PATIENTS IN A LOW RESOURCED COUNTRY AND ITS EFFECT ON THEIR ACTIVATED PARTIAL THROMBOPLASTIN TIME (aPTT) RESULTS
-
Abstract Number: PB0878
The Impact of Dual Anti-platelet, Anti Coagulation Therapy on Hemostatic Plug Structure and Function
-
Abstract Number: PB1008
The impact of hematocrit on postoperative bleeding risk in patients undergoing robotic radical prostatectomy
-
Abstract Number: OC 47.5
The impact of N-linked glycosylation in C1 domain of FVIII on immunogenicity
-
Abstract Number: VPB0132
The Impact of Sex on D-Dimer Levels and Disease Outcomes in Hospitalized COVID-19 Patients
-
Abstract Number: PB0923
The incidence and risk factors of thrombotic complications in patients with diffuse large B cell lymphoma at Trang Hospital.
-
Abstract Number: OC 25.5
The Incidence and Risk Factors of Venous and Arterial Thrombosis in Ovarian Cancer Patients- Results from a Population Database
-
Abstract Number: VPB1169
The Incidence of FV Leiden and MTHFR Gene Mutations in Patients with Hemophilia A and B in the North-Western Region of Russia
-
Abstract Number: PB1036
The increase in plasma cell-free DNA in patients with venous thromboembolism is independent of DNaseI activity
-
Abstract Number: PB1407
The increased risk of venous thromboembolism (VTE) in obese pregnant women is due to more prolonged exposure to a procoagulant state.
-
Abstract Number: PB0727
The induction of Tregs by aPC depends on metabolic reprogramming and reduced αKG levels
-
Abstract Number: PB0863
The influence of hemolysis on platelet reactivity in patients undergoing aortic valve replacement surgery.
-
Abstract Number: PB0579
The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays
-
Abstract Number: PB0669
The Interobserver and Intraobserver Agreements on HEAD-US in the assessment of Hemophilic Arthropathy
-
Abstract Number: PB0039
The Key Role of Plasminogen Activator Inhibitor-1 (PAI-1) in the Thrombogenesis Difference in COVID-19-associated Pneumonia Compared to Bacterial Pneumonia
-
Abstract Number: PB1000
The Loss of High Molecular Weight Von Willebrand Factor Multimers under Shear Conditions in Sheep is Not Solely ADAMTS13 Dependent
-
Abstract Number: OC 66.3
The Lung Pro-thrombotic Niche Drives Cancer-Associated Thromboembolism via Exosomal ITGB2
-
Abstract Number: PB0718
The Management of Craniopharyngioma in a Child with Severe Factor XI Deficiency
-
Abstract Number: PO0061
The Management of Thrombotic Complications in Oncological Patients
-
Abstract Number: VPB1351
The Manipal Deep Venous Thrombosis Registry: Clinical Characterization, Treatment Patterns and 2-year Outcomes of DVT Patients in India
-
Abstract Number: OC 17.2
The measurement of a next-generation FVIII Mimetic, Mim8, using tissue factor triggered calibrated automated thrombography
-
Abstract Number: PB0763
The mTOR Pathway in Platelets Contributes to the Pathophysiology of Experimental Cerebral Malaria
-
Abstract Number: PB1132
The new era of Haemophilia in a Comprehensive Hemophilia Treatment Center in Mexico
-
Abstract Number: PB0719
The novel bispecific antibody HMB-001 enhances the haemostatic response in models of Glanzmann Thrombasthenia by targeting FVIIa to activated platelets
-
Abstract Number: PB0917
The Ottawa Score did not predict recurrent venous thromboembolism in the prospective TROPIQUE cohort study
-
Abstract Number: PB1038
The participation of plant heparinoids in the regulation of blood clotting
-
Abstract Number: PB1242
The phenotypic and genetic heterogeneity of Hermansky-Pudlack Syndrome
-
Abstract Number: PO0023
The potential differential diagnosis value of lymphocyte ratio in patients with cytopenic diseases
-
Abstract Number: PB0853
The potential of pre-activated platelets to contribute to thrombus formation
-
Abstract Number: VPB0284
The potentiality of thromboelastographic examination of newborns with venous thrombosis
-
Abstract Number: PB0040
The Predictive Role of Plasminogen Activator Inhibitor-1 (PAI-1) in the COVID-19-associated Pneumonia
-
Abstract Number: VPB1218
The predictive value of platelet specific antibodies for the first-line treatment effect in newly diagnosed pediatric ITP
-
Abstract Number: PB1329
The predictive value of pulmonary infarction in patients with acute pulmonary embolism on persistent symptoms and adverse events
-
Abstract Number: OC 03.2
The Prekallikrein and Factor XII Heavy Chains in Surface-Independent Reactions.
-
Abstract Number: PB1410
The prenatal assessment of congenital bleeding disorder in carrier women with menorrhagia
-
Abstract Number: PB0922
The Prevalence of Thrombophilia in Patients with Cancer Associated Thromboembolism
-
Abstract Number: VPB0747
The Prospective Advances of von Willebrand Factor, ADAMTS13, and Factor VIII in Severe Malaria: A Systematic Review
-
Abstract Number: PB0823
The rare VWF non-canonical splice-site variant, c.8155+6T>A, causes type 3 von Willebrand disease in homozygosity and results in perinuclear retention of VWF in endothelial cells
-
Abstract Number: VPB0843
The ratio of von Willebrand factor activity to antigen in newly diagnosed essential thrombocythemia
-
Abstract Number: VPB1219
The relationship between platelet specific antibodies and the severity of newly diagnosed pediatric ITP
-
Abstract Number: PB0767
The Relevance of Thromboinflammatory Biomarkers and their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients
-
Abstract Number: OC 09.1
The rich inner life of a thrombus – “next generation” analysis of platelet activity during thrombus formation in vivo
-
Abstract Number: OC 42.1
The risk of incident venous thromboembolism attributed to overweight and obesity: The Tromsø Study
-
Abstract Number: OC 54.5
The risk of venous thromboembolism after minor surgical procedures: A population-based case-control study
-
Abstract Number: OC 35.2
The role of Adenylyl Cyclase 6 in platelet cyclic-AMP signalling
-
Abstract Number: PB0916
The role of anticoagulation in the management of tumour thrombosis: A single centre retrospective study
-
Abstract Number: VPB1285
The Role of Endothelial Colony-Forming Cells in Acute Deep Vein Thrombosis
-
Abstract Number: PB1262
The Role of Endothelial Glycocalyx Degradation in COVID-19
-
Abstract Number: PB1287
The role of extracellular vimentin in fibrin formation
-
Abstract Number: PB1256
The role of FSAP in regulating endothelial permeability
-
Abstract Number: VPB0374
The role of miRNAs in regulation of platelet activity – a bioinformatic analysis
-
Abstract Number: OC 18.4
The role of neutrophil extracellular traps (NETs) in lower extremity artery disease (LEAD)-specific thrombosis
-
Abstract Number: PB0774
The role of platelets in chemotherapy-associated steatohepatitis
-
Abstract Number: PB0768
The role of platelets in ER stress-induced hepatic steatosis
-
Abstract Number: PB0272
The role of procoagulant microparticles in hemostasis of patients with hemolysis
-
Abstract Number: VPB0941
The Role of Selectins in Development of Acute Pulmonary Embolism in Cancer Patients.
-
Abstract Number: PB0332
The role of thrombopoietin receptor agonists in preventing surgical bleeding in patients with inherited thrombocytopenia
-
Abstract Number: PB0803
The role of VWF-ADAMTS13 axis in cisplatin-induced acute kidney injury in mice
-
Abstract Number: OC 10.4
The Role of α-Synuclein and Cysteine String Protein-α in Platelet Function
-
Abstract Number: PB0495
The safety and efficacy of direct oral anticoagulants for atrial fibrillation in patients affected by hematologic malignancies: a single-center experience
-
Abstract Number: OC 15.2
The SAXOPHONE Study; A Multi-Center, Multi-National Randomized Trial of Apixaban versus Standard of Care Anticoagulation for Thromboprophylaxis in Children with Congenital or Acquired Heart Disease
-
Abstract Number: OC 14.5
The severe thrombophilic state associated to inferior vena cava agenesis: data from a multicentre cohort of 178 patients from the IVC Agenesis Study Group Registry
-
Abstract Number: PO0007
The six episodes of ischemic stroke during 16 years. Clinical case in a young woman.
-
Abstract Number: OC 36.5
The TFPIα C-terminal tail is essential for the synergistic enhancement of TFPIα mediated inhibition of FXa by protein S and FV-short.
-
Abstract Number: PB1143
The Thrombin Generation Test represents a better tool than Factor VIII levels to assess the risk of bleedings in patients with hemophilia A
-
Abstract Number: OC 27.1
The type and frequency of bleeds in 870 children with severe hemophilia A and B on primary prophylaxis: Data from the PedNet study group
-
Abstract Number: PB0563
The ultra-sensitive Nijmegen Inhibitor Assay detects very low-titer factor VIII inhibitors.
-
Abstract Number: PB0859
The uptake and utilisation of fatty acids by platelets.
-
Abstract Number: PO0004
The use of anticoalulants is safety. Myth or reality?
-
Abstract Number: VPB0281
The use of Apixaban for thromboprophylaxis and treatment in children with cardiac disease younger than 6 months of age
-
Abstract Number: VPB1376
The Use of Aspirin Thromboprophylaxis Compared to Alternative Anticoagulants in Elective Total Hip Replacement: A Retrospective Cohort Study
-
Abstract Number: VPB0234
The Use of Mixing Tests on Some Prolonged Coagulation Tests Results Generated from Haematology Core Laboratory of Two Tertiary Hospital in Calabar. Cross River State, Nigeria
-
Abstract Number: PB0297
The use of Obinutuzumab and Ofatumumab in the treatment of immune Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB0642
The use of plasminogen activator inhibitor-1 specific Affimers as a tool to modulate fibrin clot properties and thrombosis risk
-
Abstract Number: VPB1427
The use of rotational thromboelastometry in the management of thromboprophylaxis in pregnancy
-
Abstract Number: PB0965
The Use of Transthoracic Echocardiography in Adults Hospitalized with Acute Pulmonary Embolism
-
Abstract Number: VPB1377
The use of warfarin in patients with heart diseases in Brazil and factors associated with non-adherence to treatment
-
Abstract Number: PB0712
The utility of bleeding assessment tools in fibrinogen deficiencies
-
Abstract Number: PB1099
The validation of linear One-Stage Clotting Assays (OSCA) using fully automated Multi-Dilution Analysis (MDA) in the quantification of factor activity
-
Abstract Number: PB1080
The validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents
-
Abstract Number: PB0629
The validation of new global fibrinolysis capacity assays in high tPA concentration situation and the comparison with thromboelastgraphy
-
Abstract Number: OC 64.1
The VarioPath project: Determining effect sizes of pathogenic variants in platelet disorder genes, using clinical data from 0.5M whole exome sequenced UK Biobank participants
-
Abstract Number: PB1328
The Venous Thrombosis Registry in Østfold Hospital (The TROLL registry); design and cohort description
-
Abstract Number: OC 67.5
The Von Clauss Assay Does Not Accurately Measure Total Fibrinogen Levels After Traumatic Injury. Have We Been Thinking About Fibrinogen Replacement All Wrong?
-
Abstract Number: PB0952
The von Willebrand Factor / ADAMTS13 ratio is a good indicator of venous thromboembolism risk. Results from the RETROVE project.
-
Abstract Number: PB0802
The VWF Propeptide Is A Novel Component Of Venous Thrombi In A Mouse Model Of DVT
-
Abstract Number: PB0386
The WASH-complex subunit Strumpellin regulates integrin αIIbβ3 trafficking in murine platelets
-
Abstract Number: VPB0615
Therapeutic Dose of Enoxaparin Associated with a Better Outcome for COVID-19 Hospitalized Patients
-
Abstract Number: OC 18.1
Therapeutic potential of CD146 extracellular vesicles for the treatment of atherosclerosis
-
Abstract Number: PB0558
Thigh-tourniquet application during knee arthroscopy does not induce a hypercoagulable state – A randomized trial into the effect of tourniquet use on the coagulation system.
-
Abstract Number: PB0907
Three-month outcomes in cancer patients with superficial- or deep vein thrombosis in the lower limbs. Results from the RIETE Registry.
-
Abstract Number: OC 26.4
Thrombin and ADP pathways of platelet aggregation are dysregulated in participants with diabetes in the Framingham Heart Study
-
Abstract Number: PB0219
Thrombin generation measurement in hemophilia A patients with inhibitors receiving emicizumab prophylaxis
-
Abstract Number: PB0028
Thrombin generation predicts outcomes in patients with non-traumatic intracerebral hemorrhage
-
Abstract Number: PO0011
Thrombin generation test in patients with Covid-19
-
Abstract Number: PB1108
Thrombin Generation Using the ST-Genesia System in a Cohort of Healthy Asian Adults: Absolute and Normalized Values
-
Abstract Number: OC 25.4
Thrombo-inflammatory biomarkers in pulmonary embolism as stratified in cancer and non-cancer patient groups.
-
Abstract Number: VPB0111
Thrombocytopenia and Thrombosis associated with AstraZeneca ChAdOx1 nCoV-19 Vaccination – results of Australian centralized clinical triage system and functional assay testing system
-
Abstract Number: VPB0124
Thrombocytopenia in COVID-19 patients on ECMO
-
Abstract Number: OC 06.4
Thrombocytopenia in primary antiphospholipid syndrome: Association with prognosis and clinical implications
-
Abstract Number: PB0100
Thromboelastography (TEG) as an Outcome Predictor Marker of Covid-19 Patients in Malang Indonesia
-
Abstract Number: PB1388
Thromboelastography Assessing Coagulation Profile in Young Women Using Hormonal Contraception
-
Abstract Number: PB1014
Thromboelastography Characteristics in Pediatric Patients on Extracorporeal Membrane Oxygenation (ECMO)
-
Abstract Number: VPB0129
Thromboelastography Six: redefining heparin resistance in post COVID syndrome
-
Abstract Number: PB0093
Thromboembolism and its Management in Hospitalized COVID-19 Patients Using Modified Caprini Risk Score: A Single Center Experience in Ethiopia
-
Abstract Number: VPB0125
Thromboembolism in COVID-19 patients on ECMO
-
Abstract Number: VPB1293
Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients Undergoing Maintenance Hemodialysis in End Stage Renal Disease
-
Abstract Number: PB0259
Thrombolytic therapy in neonates and children: a twelve-year prospective registry of a single tertiary pediatric center in Argentina.
-
Abstract Number: VPB0646
Thrombolytic therapy in pulmonary embolism patients with thrombocytopenia: a systematic review
-
Abstract Number: PB0947
Thrombophilia Screening in Patients with Ocular Venous Thrombosis
-
Abstract Number: PO0074
Thrombophilic status and reproductive health of women in the Trans-Baikal Territory
-
Abstract Number: OC 59.1
Thrombopoiesis has a unique lipidomic profile enriched in polyunsaturated fatty acids that facilitates megakaryocyte maturation and platelet production
-
Abstract Number: OC 73.3
Thrombopoietin receptor agonists (TPO-RAs) in older patients with primary immune thrombocytopenia (ITP): effective and safe? Real World Data from the UK adult ITP registry.
-
Abstract Number: PB1355
Thromboprophylaxis during lower limb immobilisation after injury – a review of 2 years’ practice at King’s College Hospital, London.
-
Abstract Number: PB0066
Thromboprophylaxis outcome in childhood SARS-CoV-2 infection: A single-center experience
-
Abstract Number: OC 61.2
Thrombosis and major bleeding in patients with severe COVID-19 supported by extracorporeal membrane oxygenation (ECMO)- multicentre observational study in UK
-
Abstract Number: PB0271
Thrombosis risk in children with acute lymphoblastic leukimia during the therapy
-
Abstract Number: VPB0618
Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19
-
Abstract Number: OC 08.2
Thrombotic and Bleeding Complications in Paediatric Inflammatory Multisystem Syndrome Temporarily Associated with COVID-19 (PIMS-TS) in Children: a Systematic Review
-
Abstract Number: VPB1349
Thrombotic events as a manifestation of vasculitis/vasculopathy induced by cocaine adulterated with levamisole in a Colombian cohort.
-
Abstract Number: VPB0438
Thrombotic events of the spleno-portal axis in pre and post liver transplantation
-
Abstract Number: PB0954
Thrombotic profile according to antithombin deficiency and SERPINC1 gene analysis: a French retrospective cohort study.
-
Abstract Number: VPB0531
Thrombotic state of readiness with increase of physical activity
-
Abstract Number: VPB0312
Thrombotic thrombocytopenic purpura in adult-onset Still’s disease
-
Abstract Number: VPB0311
Thrombotic Thrombocytopenic Purpura mimicking acute Ischemic stroke
-
Abstract Number: OC 26.5
Thyroid hormones and analogues promote the acute release of platelets from megakaryocytes: from blood donor biology to the production of platelets in vitro
-
Abstract Number: PB0378
Ticagrelor enhances platelet TP receptor surface expression in patients due to P2Y12 / TP dimerization
-
Abstract Number: PB0762
Ticagrelor prevents infective endocarditis by mitigating Staphylococcus aureus virulence
-
Abstract Number: OC 14.1
Time trends in prognosis of pulmonary embolism in The Netherlands (2013-2018)
-
Abstract Number: PB1033
Tissue factor (TF) in peripheral blood mononuclear cells (PBMCs) is regulated by PACMA-31 through transcriptional and posttranscriptional mechanisms
-
Abstract Number: PB0457
Title: Retrospective study of COVID patients diagnosed with VTE
-
Abstract Number: PB0278
To Load or not to Load: Safety and Efficacy of Warfarin Dosing in Pediatric Cardiology Patients
-
Abstract Number: PB0650
To predict the impact of low dose prophylaxis vs. on demand treatment in severe Hemophilia A patients in Pakistan
-
Abstract Number: OC 72.5
Toll-Like Receptor 4-Dependent and Independent platelet-dependent thrombosis in SARS-CoV-2 Infection
-
Abstract Number: PB0476
Total Thrombus Formation Analysis System (T-TAS) Detects Poor Clot Formation in a Swine Model of Polytrauma and Hemorrhagic Shock
-
Abstract Number: OC 47.3
Towards Explaining the Unique Bleeding Pattern of Acquired Hemophilia A: Impact of FVIII-containing Immune Complexes on Hemostasis
-
Abstract Number: OC 72.4
Toxicity of neutrophil extracellular traps (NETs) and the effects of platelet factor 4 (PF4) on NET thrombogenicity: Therapeutic implications
-
Abstract Number: VPB1045
Transcriptome-wide Association Studies reveal novel genes regulating plasma levels of hemostatic factors
-
Abstract Number: OC 45.4
Transcriptomic Analysis Of Plasma And Thrombus Extracellular Vesicles (Evs) For The Molecular Diagnosis Of Ischemic Stroke Etiology
-
Abstract Number: OC 12.1
Transgene expression patterns after AAV8 delivery using hepatocyte promoter elements reveal expression in both hepatocytes and liver sinusoidal endothelial cells (LSECs)
-
Abstract Number: PB0652
Transition readiness among Dutch adolescents and young adults with haemophilia: a questionnaire study
-
Abstract Number: PB1371
Translation and Validation of the Caprini Risk Assessment Score for Urdu Speakers
-
Abstract Number: OC 37.1
Transplacental delivery of recombinant Fc-fused factor VIII (rFVIIIFc) in FVIII-deficient mice.
-
Abstract Number: OC 50.1
Transplantation of fetal liver and adult bone marrow cells for phenotypic correction of hemophilia A.
-
Abstract Number: PB0864
TRAP-Induced platelet reactivity is inhibited by omega-3 fatty acid-derived prostaglandin E3 (PGE3).
-
Abstract Number: PB1274
Trauma Induces Intravascular Hemolysis, which is Associated with Adverse Clinical Outcomes: Potential Role of Released Arginase-1, Depletion of L-arginine, and Reduced Production of Nitric Oxide
-
Abstract Number: VPB0313
Treatment and prognosis of children with inherited TTP: a single-center retrospective clinical study
-
Abstract Number: PB0340
Treatment by Line in Patients With Persistent and Chronic Immune Thrombocytopenia, A Real-World Point-In-Time Study
-
Abstract Number: PO0003
Treatment challenge of an intracranial hemorrhage: a life-threatening complication of aplastic anemia
-
Abstract Number: OC 30.3
Treatment Experience in Hemophilia Patients With and Without Inhibitors on Concizumab Prophylaxis: Hemo-TEM results from the phase 2 explorer4 & 5 studies
-
Abstract Number: OC 21.3
Treatment of Canine Hemophilia A via Intraosseous Delivery of a Platelet-Specific Factor VIII-Lentiviral Vector
-
Abstract Number: PB0754
Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: a novel therapy exploiting tumor-platelet interactions
-
Abstract Number: PB0938
Treatment of Splanchnic Vein Thrombosis with Anticoagulant Therapy in Cancer Patients: A Systematic Review and Meta-analysis
-
Abstract Number: PB1025
Treatment with Peptide KRRKPGP and Warfarin Changes Anticoagulant Effects and Fibrinolysis in Metabolic Syndrome
-
Abstract Number: VPB0757
TREGs-induced Immune Thrombotic Thrombocytopenia in Polycythemia Vera
-
Abstract Number: PB0442
Two Stage Intravital Imaging Mouse Model to Assess Venous Thromboembolism in Sickle Cell Disease
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.